Enhancement of p53 activity and inhibition of neural cell proliferation by glucocorticoid receptor activation

FASEB Journal

Volumn 16, Issue 8, 2002, Pages 761-770

  Crochemore, Christophe ^a   Michaelidis, Theologos M ^b   Fischer, Dieter ^a   Loeffler, Jean Philippe ^a   Almeida, Osborne F X ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Apoptosis; Cell cycle arrest; Corticosteroid; HT 22 neural cell line

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; PROTEIN BAX; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL DEATH; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; GENE ACTIVITY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; NERVE CELL; PRIORITY JOURNAL; PROTEIN STABILITY; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; BIOLOGICAL TRANSPORT; CELL CYCLE; CELL DIVISION; CELL LINE; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DEXAMETHASONE; FLOW CYTOMETRY; G1 PHASE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HORMONE ANTAGONISTS; HUMANS; IN SITU NICK-END LABELING; MIFEPRISTONE; NEURONS; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036275355     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.01-0577com     Document Type: Article

References (85)

1. In vivo resistance to glucocorticoid-induced apoptosis in rat thymocytes with normal steroid receptor function in vitro
2. Mechanisms of T-cell apoptosis induced by glucocorticoids
3. Stress and hippocampal neurogenesis
4. Prolonged glucocorticoid exposure reduces hippocampal neuron number: Implications for aging
5. Controversies surrounding glucocorticoid-mediated cell death in the hippocampus
6. Cortisol levels during human aging predict hippocampal atrophy and memory deficits
7. Ligand and subfield specificity of corticoid-induced neuronal loss in the rat hippocampal formation
8. Exacerbation of apoptosis in the dentate gyrus of the aged rat by dexamethasone and the protective role of corticosterone
9. Subtle shifts in the ratio between proand antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate
10. Biochemical effects of corticosteroids on neural tissues
11. The effects of serum depletion and dexamethasone on growth and differentiation of human neuroblastoma cell lines
12. Steroid hormone receptors: Many actors in search of a plot
13. Selective loss of hippocampal granule cells in the mature rat brain after adrenalectomy
14. Effects of aldosterone or RU28362 treatment on adrenalectomy-induced cell death in the dentate gyrus of the adult rat
15. Tumor suppressor p53 induction and DNA damage in hippocampal granule cells after adrenalectomy
16. p53: Puzzle and paradigm
17. Neuronal life and death: An essential role for the p53 family
18. Regulation of p53 function
19. Tumorsuppressor p53 is expressed in proliferating and newly formed neurons of the embryonic and postnatal rat brain: Comparison with expression of the cell cycle regulators p21Waf1/Cip1, p27Kip1, p57Kip2, p16Ink4a, cyclin G1, and the proto-oncogene Bax
20. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells
21. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation
22. Targeted in vivo expression of the cyclindependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration
23. Genetic determinants of p53-induced apoptosis and growth arrest
24. Regulation of p53 downstream genes
25. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
26. Transplantation of a temperature-sensitive, nerve growth factor-secreting, neuroblastoma cell line into adult rats with fimbria-fornix lesions rescues cholinergic septal neurons
27. Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line
28. Suppression of human colorectal carcinoma cell growth by wild-type p53
29. Oncogenic forms of p53 inhibit p53-regulated gene expression
30. Primary structure and expression of a functional human glucocorticoid receptor cDNA
31. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine
32. Gene transfer optimization with lipospermine-coated DNA
33. Protein measurement with the Folin phenol reagent
34. Rapid detection of octamer binding proteins with mini-extracts, prepared from a small number of cells
35. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
36. Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro
37. DNA binding properties of glucocorticosteroid receptors bound to the steroid antagonist RU-486
38. RU486 (mifepristone): Mechanisms of action and clinical uses
39. Glucocorticoid-induced alterations of morphology and growth of fibrosarcoma cells derived from 7,12-dimethylbenz(a)anthracene rat mammary tumor
40. Kirsten sarcoma virus-immortalized mast cell lines. Reversible inhibition of growth by dexamethasone and evidence for the presence of an autocrine growth factor
41. Distinct glucocorticoid receptor transcriptional regulatory surfaces mediate the cytotoxic and cytostatic effects of glucocorticoids
42. Apoptosis: The biochemistry and molecular biology of programmed cell death
43. Transcriptional control of steroid-regulated apoptosis in murine thymoma cells
44. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes
45. Glucocorticoids inhibit bone resorption by isolated rat osteoclasts by enhancing apoptosis
46. Intragenic sequences of the human glucocorticoid receptor complementary DNA mediate hormone-inducible receptor messenger RNA down-regulation through multiple mechanisms
47. One mechanism for cell type-specific regulation of the bax promoter by the tumor suppressor p53 is dictated by the p53 response element
48. Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms
49. p53 stimulates promoter activity of the sgk serum/glucocorticoid-inducible serine/threonine protein kinase gene in rodent mammary epithelial cells
50. Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant
51. CDK inhibitors: Positive and negative regulators of G1-phase progression
52. Modulation of apoptosis-associated genes bcl-2, bcl-x and bax during rat liver regeneration
53. Ontogeny of type I and type II corticosteroid receptors in the rat hippocampus
54. Plasticity of hippocampal corticosteroid receptors during aging in the rat
55. Alteration in glucocorticoid binding site number during the cell cycle in HeLa cells
56. Glucocorticoids in cancer therapy
57. Resistance to glucocorticoidinduced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression
58. p53, the cellular gatekeeper for growth and division
59. p53 and apoptosis
60. p73 is a human p53-related protein that can induce apoptosis
61. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers
62. Regulation of the p53 tumor suppressor protein
63. Ligand-dependent inteaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2
64. Regulation of the specific DNA binding function of p53
65. Stabilization and activation of p53 are regulated independently by different phosphorylation events
66. Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells
67. Mechanism of gene expression by the glucocorticoid receptor: Role of protein-protein interactions
68. The coregulator exchange in transcriptional functions of nuclear receptors
69. Acetylation of histones and transcription-related factors
70. Glucocorticoids reversibly arrest rat hepatoma cell growth by inducing an early G1 block in cell cycle progression
71. Glucocorticoid regulation of G1 cyclin-dependent kinase genes in lymphoid cells
72. Involvement of the cell cycle inhibitor C1P1/WAF1 in lung alveolar epithelial cell growth arrest induced by glucocorticoids
73. Glucocorticoid inhibition of fibroblast proliferation and regulation of the cyclin kinase inhibitor p21Cip1
74. Glucocorticoids stimulate p21 gene expression by targeting multiple transcriptional elements within a steroid responsive region of the p21 waf1/cip1 promote in rat hepatoma cells
75. Role of the CCAAT/enhancer binding protein-alpha transcription factor in the glucocorticoid stimulation of p21waf1/cip1 gene promoter activity in growtharrested rat hepatoma cells
76. The p53 network
77. Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest
78. Transcriptional activation by p53 correlates with suppression of growth but not transformation
79. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts
80. Sequence-specific transcriptional activation is essential for growth suppression by p53
81. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations
82. p53 in signaling checkpoint arrest or apoptosis
83. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells
84. p53 expression induces apoptosis in hippocampal pyramidal neuron cultures
85. Use of corticosteroids in neuro-oncology